Merus Stock Target Raised Following Impressive Trial Outcomes
Tuesday, 4 June 2024, 09:32
Merus Stock Target Raised
Analysts have revised the price target for Merus shares following the announcement of strong trial data.
Maintains Buy Rating
Merus shares received a Buy rating from analysts, signaling confidence in the company's performance.
- Positive trial results led to the surge in Merus stock prices
- Analysts raised the target price in response to the impressive outcomes
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.